Lone Star Value Management buys $5.1 Million stake in Digirad Corporation (DRAD)

Digirad Corporation (DRAD) : Lone Star Value Management scooped up 15,940 additional shares in Digirad Corporation during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 13, 2016. The investment management firm now holds a total of 957,155 shares of Digirad Corporation which is valued at $5.1 Million.Digirad Corporation makes up approximately 10.62% of Lone Star Value Management’s portfolio.

Other Hedge Funds, Including , Driehaus Capital Management sold out all of its stake in DRAD during the most recent quarter. The investment firm sold 17,120 shares of DRAD which is valued $90,394.Spark Investment Management reduced its stake in DRAD by selling 1,200 shares or 7.84% in the most recent quarter. The Hedge Fund company now holds 14,100 shares of DRAD which is valued at $74,448. Digirad Corporation makes up approx 0.01% of Spark Investment Management’s portfolio.Gsa Capital Partners Llp boosted its stake in DRAD in the latest quarter, The investment management firm added 21,127 additional shares and now holds a total of 80,856 shares of Digirad Corporation which is valued at $426,920. Digirad Corporation makes up approx 0.03% of Gsa Capital Partners Llp’s portfolio.

Digirad Corporation closed down -0.05 points or -0.96% at $5.14 with 44,233 shares getting traded on Wednesday. Post opening the session at $5.24, the shares hit an intraday low of $5.1 and an intraday high of $5.24 and the price fluctuated in this range throughout the day.Shares ended Wednesday session in Red.

Digirad Corporation is a provider of diagnostic solutions. The Company’s business is organized into two segments: Diagnostic Services and Diagnostic Imaging. The Company provides in-office nuclear cardiology and ultrasound imaging services and also provides cardiac event monitoring services to physician practices hospitals and imaging centers through its Diagnostic Services business segment. The Company sells medical diagnostic imaging systems including solid-state gamma cameras for nuclear cardiology and general nuclear medicine applications as well as provides service on the products it sells through its Diagnostic Imaging business segment. The Company’s imaging systems are sold in both portable (movable) and fixed (stationary) configurations which include Cardius XPO Cardius X-ACT and ergo gamma cameras.

Leave a Reply

Digirad Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Digirad Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.